Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7
NCT03761537
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
277
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Tralokinumab
OTHER:
Placebo
Sponsor
LEO Pharma